Publication | Closed Access

Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer

Breast OncologyMedicineMetronomic TherapyPharmacologyPhase Ii StudyBreast CancerPharmacotherapyMetronomic ChemotherapyCancer TreatmentOncology